The patenting activities of innovative biotechnology firms - ARCHIVED

Articles and reports: 88-003-X20050038769


In Canada, innovative biotechnology firms invest large amounts to develop new biotechnology products and processes. In 2003, they invested nearly $1.5 billion in research and development (R&D). In biotechnology, the development process is long and costly, with no guarantee of success. Some firms that discover a new biotechnology product or process with potential industrial applications may want to protect it against any infringement. The patent is a tool preferred by innovative biotechnology firms to protect their invention. This short article describes the patenting activities of biotechnology firms in 2003 and examines the relationship between patents and funding.

Issue Number: 2005003
Author(s): Maheux, Hélène
FormatRelease dateMore information
PDFOctober 26, 2005